Start Date
September 30, 2013
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2017
RAD001
"Dosing schedule of RAD001 for the Phase I portion:~Regimen 1. 5.0 mg q72 hours (400 mg QD); Regimen 2. 5 mg q48 hours (400 mg QD); Regimen 3. 5.0 mg q day (400 mg QD); Regimen 4. 7.5 mg PO q day (400 mg QD."
Imatinib
Imatinib will be given continuously at a fixed daily dose of 400 mg once daily.
University of Michigan Health System, Ann Arbor
Collaborators (1)
Novartis
INDUSTRY
University of Michigan Rogel Cancer Center
OTHER